Abstract
The proinflammatory state of metabolic disorders encompasses the alterations in leukocyte counts and acute-phase reactants, and thus, predisposes to acute and chronic cardiovascular events linked to fat accumulation. Leptin is a marker of adiposity and also yields regulatory effects on innate and adaptive immunity; however, its role on the immune function of obese subjects remains to be elucidated. The aim of this study is to determine the influence of obesity and the role of leptin concentrations on lymphocyte counts and immunoglobulin levels as broad markers of immune function. Cross-sectional analysis in 147 obese (64 M, BMI 43 ± 8.1 kg/m2) and 111 age- and sex-matched controls (36 M, BMI 22.5 ± 2.6 kg/m2) by assessment of peripheral leukocyte counts, immunoglobulin (Ig) A, G, M levels, leptin, glucose and lipid homeostasis, and acute-phase reactants. Compared to controls, all the leukocyte components were significantly increased in obesity (p < 0.0001 for all) except for basophils and eosinophils. While IgA and IgG levels were similar between groups, IgM levels were lower (p < 0.001) in obese individuals. A significant relationship was evident between leptin and leukocyte counts (p < 0.001), with this latter being correlated to insulin resistance, adiposity, and lipid profile. At the stepwise multiple regression analysis, leukocytes were best predicted by leptin (β = 0.43, p < 0.0001) and male gender (β = 0.15, p < 0.05), yet when obesity entered the equation, it acted as an independent predictor of leukocytes (β = 0.51, p < 0.0001). Leptin also acted as a predictor of IgA levels (β = 0.20, p < 0.01). Current results show that IgM levels are significantly decreased in patients with obesity in association to significant increments in leukocyte counts. These latter are markedly correlated to leptin levels, insulin resistance, lipid profile, and adiposity. This circumstance, and the significant correlation seen between leptin and IgA levels, may suggest an indirect intervention of leptin in the immunologic alterations consequent to obesity and related to its cardiovascular risk.
Similar content being viewed by others
References
R.A. Durazo-Arvizu, U. Goldbourt, D.L. McGee, Body-mass index and mortality. New Engl. J. Med. 342, 287–289 (2000)
E.S. Ford, Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care 22, 1971–1977 (1999)
M. Bullo, P. Garcia-Lorda, I. Megias, J. Salas-Salvadó, Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. Res. 1, 525–531 (2003)
J.P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, B. Hainque, Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85, 3338–3342 (2000)
D.S. Freedman, M.R. Joesoef, J.J. Barboriak, D.D. Stallone, T. Byers, Correlates of leukocyte counts in men. Ann. Epidemiol. 6, 74–82 (1996)
T. Hasegawa, T. Negishi, M. Deguchi, WBC count, atherosclerosis and coronary risk factors. J. Atheroscler. Thromb. 9, 219–223 (2002)
A. Gonzalez-Quintela, R. Alende, F. Gude, J. Campos, J. Rey, L.M. Meijide, C. Fernandez-Merino, C. Vidal, Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin. Exp. Immunol. 151, 42–50 (2008)
M.H. Criqui, E.R. Lee, R.N. Hamburger, M.R. Klauber, S.S. Coughlin, IgE and cardiovascular disease: results from a population-based study. Am. J. Med. 82, 964–968 (1987)
A. Muscari, C. Bozzoli, C. Gerratana, F. Zaca’, C. Rovinetti, D. Zauli, M. La Placa, P. Puddu, Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74, 179–186 (1988)
P.T. Kovanen, M. Manttari, T. Palosuo, V. Manninen, K. Aho, Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch. Intern. Med. 158, 1434–1439 (1998)
G. Matarese, C. Procaccini, V. De Rosa, T.L. Horvath, A. La Cava, Regulatory T cells in obesity: the leptin connection. Trends Mol. Med. 16, 247–256 (2010)
P. Marzullo, A. Minocci, M.A. Tagliaferri, G. Guzzaloni, A. Di Blasio, C. De Medici, G. Aimaretti, A. Liuzzi, Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J. Clin. Endocrinol. Metab. 95, 3965–3972 (2010)
K. Claycombe, L.E. King, P.J. Fraker, A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc. Nat. Acad. Sci. USA 105, 2017–2021 (2008)
F. Lago, C. Dieguez, J. Gómez-Reino, O. Gualillo, Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Pract. Rheumatol. 3, 716–724 (2007)
R. Faggioni, K.R. Feingold, C. Grunfeld, Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 15, 2565–2571 (2001)
P. Fernández-Riejos, S. Najib, J. Santos-Alvarez, C. Martín-Romero, A. Pérez-Pérez, C. González-Yanes, V. Sánchez-Margalet, Role of leptin in the activation of immune cells. Mediat. Inflamm. 2010, 568343 (2010)
S. Taleb, O. Herbin, H. Ait-Oufella, W. Verreth, P. Gourdy, V. Barateau, R. Merval, B. Esposito, K. Clément, P. Holvoet, A. Tedgui, Z. Mallat, Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2691–2698 (2007)
S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, A.W. Ferrante Jr, Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003)
H. Xu, G.T. Barnes, Q. Yang, G. Tan, D. Yang, C.J. Chou, J. Sole, A. Nichols, J.S. Ross, L.A. Tartaglia, H. Chen, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003)
V. Bittner, Atherosclerosis and the immune system. Arch. Intern. Med. 158, 1395–1396 (1998)
D.A. Winer, S. Winer, L. Shen, P.P. Wadia, J. Yantha, G. Paltser, H. Tsui, P. Wu, M.G. Davidson, M.N. Alonso, H.X. Leong, A. Glassford, M. Caimol, J.A. Kenkel, T.F. Tedder, T. McLaughlin, D.B. Miklos, H.M. Dosch, E.G. Engleman, B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610–617 (2011)
D. Cipolletta, M. Feuerer, A. Li, N. Kamei, J. Lee, S.E. Shoelson, C. Benoist, D. Mathis, PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486, 549–553 (2012)
S. Winer, Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, Y. Maezawa, D.J. Drucker, E. Engleman, D. Winer, H.M. Dosch, Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921–929 (2009)
H. Yang, Y.H. Youm, B. Vandanmagsar, A. Ravussin, J.M. Gimble, F. Greenway, J.M. Stephens, R.L. Mynatt, V.D. Dixit, Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J. Immunol. 185, 1836–1845 (2010)
K. van der Weerd, W.A. Dik, B. Schrijver, D.H. Schweitzer, A.W. Langerak, H.A. Drexhage, R.M. Kiewiet, M.O. van Aken, A. van Huisstede, J.J. van Dongen, A.-J. van der Lelij, F.J. Staal, P.M. van Hagen, Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes 61, 401–408 (2012)
Y. Herishanu, O. Rogowski, A. Polliack, R. Marilus, Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur. J. Haematol. 76, 516–520 (2006)
I.R. Fisch, S.H. Freedman, Smoking, oral contraceptives, and obesity. Effects on white blood cell count. J. Am. Med. Assoc. 234, 500–506 (1975)
J. Schwartz, S.T. Weiss, Host and environmental factors influencing the peripheral blood leukocyte count. Am. J. Epidemiol. 134, 1402–1409 (1991)
A. Festa, R. D’Agostino Jr, G. Howard, L. Mykkänen, R.P. Tracy, S.M. Haffner, Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42–47 (2000)
W.S. Shim, H.J. Kim, E.S. Kang, C.W. Ahn, S.K. Lim, H.C. Lee, B.S. Cha, The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res. Clin. Pract. 73, 284–291 (2006)
C.D. Lee, A.R. Folsom, F.J. Nieto, L.E. Chambless, E. Shahar, D.A. Wolfe, White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women. Am. J. Epidemiol. 154, 758–764 (2001)
M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41, 374–383 (2012)
S. Rodriguez-Segade, M.F. Camiña, J.M. Paz, R. Del Rio, Abnormal serum immunoglobulin concentrations in patients with diabetes mellitus. Clin. Chim. Acta 203, 135–142 (1991)
M. Jagannathan, M. McDonnell, Y. Liang, H. Hasturk, J. Hetzel, D. Rubin, A. Kantarci, T.E. Van Dyke, L.M. Ganley-Leal, B.S. Nikolajczyk, Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 53, 1461–1471 (2010)
A. Bouman, M.J. Heineman, M.M. Faas, Sex hormones and the immune response. Hum. Reprod. Updat. 11, 411–423 (2005)
H. Feng, L. Zheng, Z. Feng, Y. Zhao, N. Zhang (2012) The role of leptin in obesity and the potential for leptin replacement therapy. Endocrine Dec 29 [Epub ahead of print]
X. L. Ye, C. F. Lu (2013) Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis. Endocrine Mar 5 [Epub ahead of print]
S.J. Motivala, J. Dang, T. Obradovic, G.G. Meadows, A.W. Butch, M.R. Irwin, Leptin and cellular and innate immunity in abstinent alcoholics and controls. Alcohol. Clin. Exp. Res. 27, 1819–1824 (2003)
C.J. Hukshorn, J.H. Lindeman, K.H. Toet, W.H. Saris, P.H. Eilers, M.S. Westerterp-Plantenga, T. Kooistra, Leptin and the proinflammatory state associated with human obesity. J. Clin. Endocrinol. Metab. 89, 1773–1778 (2004)
J.A. Meyers, A.Y. Liu, A. McTiernan, M.H. Wener, B. Wood, D.S. Weigle, B. Sorensen, Z. Chen-Levy, Y. Yasui, A. Boynton, J.D. Potter, C.M. Ulrich, Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women. J. Endocrinol. 199, 51–60 (2008)
Acknowledgments
This study was partly founded by Progetto di Ricerca Corrente 18C004_2010 from the Italian Ministry of Health. This study is encompassed in the activities of the Interdisciplinary Research Centre for Autoimmune Diseases (IRCAD), Novara, Italy.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marzullo, P., Minocci, A., Giarda, P. et al. Lymphocytes and immunoglobulin patterns across the threshold of severe obesity. Endocrine 45, 392–400 (2014). https://doi.org/10.1007/s12020-013-0006-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0006-z